How much does Dexcel-Pharma Limited make?

Dexcel-Pharma Limited reported revenue of £39.1m and £3.7m profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Dexcel-Pharma Limited have?

Dexcel-Pharma Limited reported an average of 25 employees in the year to 31 Dec 2025.

Is Dexcel-Pharma Limited profitable?

Yes — Dexcel-Pharma Limited reported a profit of £3.7m in the year to 31 Dec 2025.

Company No. 02963398 · Incorporated 31 Aug 1994

Dexcel-Pharma Limited

Registered name: DEXCEL-PHARMA LIMITED

Part of Dexcel Pharma Laboratories Ltd group

Dexcel-Pharma Limited made £39.1m revenue and £3.7m profit in the year to 31 Dec 2025.

Dexcel-Pharma Limited’s revenue was £39.1m in the year to 31 Dec 2025, with £3.7m profit and 25 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Coventry; we hold 4 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Coventry, West Midlands
Age: 32 yrs · since 1994
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Dexcel-Pharma Laboratories Limited”

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

£39.1m

Growth —

Profit

£3.7m

Growth —

Profit margin

9.3%

Gross 41.4%

Employees

Change —

Profit / employee

£146k

Revenue/employee £1.6m

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2021	30 Jun 2023	30 Jun 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£17.1m	£27.6m	£21.5m	£39.1m
Cost of sales	£12.7m	£19m	£13.6m	£22.9m
Gross profit	£4.4m	£8.6m	£7.9m	£16.2m
Operating profit	£838k	£2.9m	£1.8m	£4.7m
Profit before tax	£838k	£2.9m	£1.9m	£4.9m
Profit after tax	£838k	£2.3m	£1.5m	£3.7m
Profit (best available)	£838k	£2.3m	£1.5m	£3.7m
Staff costs	£1.4m	£2.1m	£1.6m	£3m
Employees (average)	20	21	22	25
Ratios
Profit margin	4.9%	8.5%	6.8%	9.3%
Gross margin	25.8%	31.1%	36.8%	41.4%
Revenue per employee	£853k	£1.3m	£979k	£1.6m
Profit per employee	£41.9k	£111k	£66.9k	£146k
Growth (year on year)
Revenue growth	—	—	▼21.9%	—
Profit growth	—	—	▼36.9%	—
Headcount growth	—	—	▲4.8%	—
Balance sheet — indirect signals, not revenue
Cash at bank	£2.3m	£3.2m	£2.4m	£4.3m
Net assets	£11.8m	£14.2m	£21.9m	£25.5m
Fixed assets	£5.4m	£4.5m	£17.2m	£14.8m
Current assets	£12.3m	£16.1m	£17.7m	£20.8m
Debtors	£3.2m	£4.2m	£5.9m	£5.7m
Deferred income	£479k	£1.9m	£751k	£1.2m
Source	Accounts · bulk data Mar 2024	Accounts · bulk data Mar 2024	FullAccounts · bulk data Mar 2025	FullAccounts · bulk data Sep 2026

Derived from the latest filing

How the business works

Profit margin: 9.3%; Profit ÷ revenue.
Gross margin: 41.4%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £1.6m; Revenue ÷ average employees.
Profit per employee: £146k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 37.9%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 3.1%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 14.5%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now £25.5m
Cash at bank: —; Now £4.3m
Headcount: —; Now 25
Deferred income: —; Now £1.2m
Fixed assets: —; Now £14.8m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Dexcel Pharma Laboratories Ltd (registered outside the UK register)ultimate parent75–100%
Dexcel-Pharma Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £3.7m), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.